DrugPatentWatch Database Preview
NEUPRO Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Neupro, and what generic alternatives are available?
Neupro is a drug marketed by Ucb Inc and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in NEUPRO is rotigotine. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rotigotine profile page.
Summary for NEUPRO
| US Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 57 |
| Clinical Trials: | 33 |
| Patent Applications: | 113 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NEUPRO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NEUPRO |
| DailyMed Link: | NEUPRO at DailyMed |
Generic Entry Opportunity Date for NEUPRO
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for NEUPRO
| (-)-(S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol |
| (-)-N-0437 |
| (2S)-2-[propyl-[2-(2-thienyl)ethyl]amino]tetralin-5-ol |
| (6S)-6-(propyl-(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol |
| (6S)-6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol |
| (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol |
| (S)-(-)-Rotigotine |
| (S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol |
| (S)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol |
| (S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol |
| (S)-6-[Propyl-(2-thiophen-2-yl-ethyl)-amino]-5,6,7,8-tetrahydro-naphthalen-1-ol |
| 1-naphthalenol, 5,6,7,8-tetrahydro-6-(propyl (2-(2-thienyl)ethyl)amino-(6S)- |
| 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, (6S)- |
| 2-(N-n-Propyl-N-2-thienylethylamino)-5-hydroxytetralin |
| 2696AH |
| 572R932 |
| 87T4T8BO2E |
| 99755-59-6 |
| A846076 |
| AB0088886 |
| AC-3547 |
| AC1L1QQG |
| AJ-08188 |
| AKOS016340728 |
| AN-12885 |
| API0026245 |
| BC677693 |
| BDBM50123626 |
| C19H25NOS |
| CAS-99755-59-6 |
| CHEBI:135351 |
| CHEMBL1303 |
| CS-0376 |
| CTK8E7903 |
| Cyclopentylcytosine |
| D05768 |
| D08XAW |
| D09OQV |
| DB05271 |
| DSSTox_CID_26772 |
| DSSTox_GSID_46772 |
| DSSTox_RID_81893 |
| DTXSID5046772 |
| EX-A1164 |
| FT-0771906 |
| GTPL941 |
| HSDB 8254 |
| HY-75502 |
| J-502471 |
| KFQYTPMOWPVWEJ-INIZCTEOSA-N |
| KS-00002WXX |
| Leganto |
| LS-178435 |
| MFCD00870193 |
| MolPort-005-941-578 |
| N 0437 |
| N 0437, (-)-isomer |
| N 0923 |
| N-0437 |
| N-0923 |
| NCGC00168748-01 |
| NCGC00168748-02 |
| Neupro (TN) |
| PubChem16423 |
| RL06136 |
| Rotigotine |
| Rotigotine (JAN/USAN/INN) |
| Rotigotine (USAN/INN) |
| Rotigotine [USAN:INN:BAN] |
| Rotigotine [USAN:INN] |
| Rotigotine CDS |
| Rotigotine CDS Patch |
| RT-015446 |
| s4274 |
| SC-22242 |
| SCHEMBL1088585 |
| SPM 962 |
| SPM-936 |
| SPM-937 |
| SPM-962 |
| SS-4572 |
| Tox21_112627 |
| Tox21_112627_1 |
| UNII-5QTR54Z0E1 component KFQYTPMOWPVWEJ-INIZCTEOSA-N |
| UNII-87T4T8BO2E |
| W-5179 |
| ZINC4028 |
US Patents and Regulatory Information for NEUPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-006 | Apr 2, 2012 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-002 | May 9, 2007 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-006 | Apr 2, 2012 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-002 | May 9, 2007 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-003 | May 9, 2007 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-002 | May 9, 2007 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Paragraph IV (Patent) Challenges for NEUPRO
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Transdermal Film | 1 mg/24 hr, 2 mg/24 hr, 3 mg/24 hr,4 mg/24 hr,6 mg/24 hr, and 8 mg/24 hr | ➤ Subscribe | ➤ Sign Up |
see a sample report or, see our see our flat-rate plans
International Patents for NEUPRO
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Norway | 333297 | ➤ Sign Up |
| Taiwan | I272108 | ➤ Sign Up |
| Mexico | PA05000349 | ➤ Sign Up |
| Czech Republic | 20021867 | ➤ Sign Up |
| South Africa | 200204148 | ➤ Sign Up |
| Austria | 245972 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for NEUPRO
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 269 | Luxembourg | ➤ Sign Up | 91269, EXPIRES: 20210215 |
| 1033978/01 | Switzerland | ➤ Sign Up | TEILUEBERTRAGUNG |
| 00236 | Netherlands | ➤ Sign Up | PRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001-013 20060215 |
| 2006 00020 | Denmark | ➤ Sign Up | PRODUCT NAME: ROTIGOTINE |
| C0025 | France | ➤ Sign Up | PRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 20060215 |
| 24/2006 | Austria | ➤ Sign Up | PRODUCT NAME: ROTIGOTINE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
